AvicannaAVCNF -2.55%53 Days Inventory is 127.05 as of Mar. 2026, which is 58% below its 10-year median of 300.95. GuruFocus rates AVCNF with a GF Score™ of 53/100 and a GF Value™ of $0.20 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 916 Drug Manufacturers companies, Avicanna ranks better than 65.94% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Avicanna's Average Total Inventories for the
three
months ended in Mar. 2026 was $2.89 Mil. Avicanna's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $2.07 Mil.
Hence, Avicanna's Days Inventory for the
three
months ended in Mar. 2026 was 127.05.
The historical rank and industry rank for Avicanna's Days Inventory or its related term are showing as below:
AVCNF'
s Days Inventory Range Over the Past 10 Years
Min: 107.53 Med: 300.95 Max: 7693.82
Current: 128.26
During the past 10 years, Avicanna's highest Days Inventory was 7693.82. The lowest was 107.53. And the median was 300.95.
AVCNF's Days Inventory is ranked better than 65.94% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs AVCNF: 128.26
Avicanna's Days Inventory
declined
from Mar. 2025 (128.18) to Mar. 2026 (127.05).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Avicanna's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.72.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avicanna's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.59.
Avicanna (OTCPK:AVCNF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Avicanna's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avicanna's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Avicanna Days Inventory Related Terms
Avicanna Days Inventory Historical Data
* Premium members only.
The historical data trend for Avicanna's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Avicanna's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avicanna Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avicanna's Days Inventory distribution charts can be found below:
* The bar in red indicates where Avicanna's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avicanna (AVCNF) has a Days Inventory of 127.05 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avicanna and its competitors. This is 58% below median its historical median of 300.95. Over the past decade, Avicanna's Days Inventory has ranged from 107.53 to 7,693.82. According to the industry distribution chart, Avicanna ranks #312 out of 916 companies in the Drug Manufacturers industry, placing it in the top 34.1%.
Is Avicanna's Days Inventory too high?
Avicanna's current Days Inventory of 127.05 is 58% below median its 10-year median of 300.95. Over the past 10 years, this metric has ranged from a low of 107.53 to a high of 7,693.82. The Drug Manufacturers industry median Days Inventory is 164.43. Avicanna's value of 127.05 is 22.7% below this industry median. Based on the distribution chart, Avicanna ranks #312 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Avicanna has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avicanna's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Avicanna ranks #312 out of 916 companies for Days Inventory. This puts Avicanna in the upper half of its industry. The industry median Days Inventory is 164.43. Avicanna's value of 127.05 is 22.7% below this benchmark. Historically, Avicanna's own Days Inventory has ranged from 107.53 to 7,693.82 over the past decade. While the company's 10-year median is 300.95 vs. the industry median of 164.43, Avicanna has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avicanna's current Days Inventory of 127.05 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avicanna and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avicanna's current Days Inventory is 127.05, which is 58% below median its own 10-year median of 300.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avicanna stock overvalued right now?
Based on GuruFocus' analysis, Avicanna (AVCNF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.20, compared to a current price of $0.09 — trading 57.5% below its estimated fair value. The current Days Inventory is 127.05, which is 58% below median its 10-year median of 300.95 and 22.7% below the Drug Manufacturers industry median of 164.43. Avicanna's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Avicanna (AVCNF), the current Days Inventory is 127.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avicanna (AVCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Avicanna stock appears to be undervalued.
The current stock price of $0.09 is trading 57.5% below its estimated GF Value™ of $0.20.
GuruFocus considers Avicanna to be Possible Value Trap.
Key valuation signals for AVCNF:
Days Inventory: 127.05 (58% below median its 10-year median of 300.95)
GF Value™: $0.20 vs. price of $0.09 (57.5% below fair value)
Industry Position: 22.7% below the Drug Manufacturers median (#312 of 916)
No single metric tells the full story. See the AVCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.
53GF Score
Get the complete analysis for AVCNF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVCNF has been successfully added to your 
